Partner Content Partner Content Intellectual Property and Regulatory Law: Recent Development... Intellectual Property Law
Partner Content Partner Content Attendee list for Biosimilars North America 2017 released Attendee list for Biosimilars North America 2017 releas
Partner Content Partner Content Can parallel distribution and industry work together? Can parallel distribution and industry work together?
Partner Content Partner Content Industry experts set to transform evolving pre-approval & un... Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma
Partner Content Partner Content Orphan medicines, advances, access and affordability LONDON, UNITED KINGDOM, April 19th 2017:
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
